← All stocks

Janux Therapeutics, Inc.

JANX Net selling
CIK 0001817713 #2496 in the set updated 19 Sep 2026
Bought (120 mo)
$207.28M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$365.17M
$6.73M on a plan · $19.32M straight out of an exercise
Sold at will
$339.13M
60 of 103 sales
Net
−$157.90M
−$131.85M against sales at will

By person

24 insiders · 125 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Avalon Ventures XI, L.P. entity
10% owner
$15.69M (2)
$205.38M (47)
−$189.69M
8,666,664
14.18%
$121.58M
+102.9%
RA CAPITAL MANAGEMENT, L.P. entity
Director
$135.21M (8)
+$135.21M
1,060,156
1.73%
$14.87M
Lichter Jay
10% owner
$15.69M (2)
$82.30M (4)
−$66.61M
7,826,510
12.80%
$109.80M
Reardon Tighe
Acting Chief Financial Officer
$15.69M (2)
$45.04M (2)
−$29.36M
7,992,445
13.07%
$112.13M
+129.3%
Campbell David Alan
President and CEO
$6.61M (11) scheduled
−$6.61M
264,742
0.4330%
$3.71M
−20.3%
Meyer Andrew Hollman
Chief Business Officer
$4.22M (19) scheduled
−$4.22M
83,095
0.1359%
$1.17M
+18.0%
ORBIMED ADVISORS LLC entity
Director
$12.00M (2)
$10.59M (6)
+$1.41M
513,496
0.8399%
$7.20M
Thompson Peter A.
Director
$12.00M (2)
$10.59M (6)
+$1.41M
513,496
0.8399%
$7.20M
Bregua Corp entity
10% owner
$999.99K (1)
+$999.99K
3,749,250
6.13%
$52.60M
DiRaimondo Thomas
Chief Scientific Officer
$266.11K (3) scheduled
−$266.11K
155,825
0.2549%
$2.19M
+44.4%
Doyle Janeen Noel
Chief Corp. & Bus. Dev. Ofcr
$56.94K (1)
−$56.94K
75,941
0.1242%
$1.07M
Dobek Maria
Vice President, Accounting
$48.95K (2)
−$48.95K
32,270
0.0528%
$452.72K
+1,038%
McIver Zachariah
Chief Medical Officer
$37.26K (1)
−$37.26K
52,286
0.0855%
$733.52K
Winter Charles M.
Chief Technical Officer
$32.97K (1)
−$32.97K
106,321
0.1739%
$1.49M
+86.1%
Gujrathi Sheila
Director
118,889
0.1945%
$1.67M
+13.2%
CAPPS VICKIE L
Director
79,598
0.1302%
$1.12M
+24.3%
Go William
Chief Medical Officer
44,000
0.0720%
$617.28K
Robinson Byron
Chief Strategy Officer
28,000
0.0458%
$392.81K
DOBMEIER ERIC
Director
15,481
0.0253%
$217.18K
Hernday Natasha
Director
15,481
0.0253%
$217.18K
Simson Jake
Director
11,750
0.0192%
$164.84K
Kung Winston
Director
11,750
0.0192%
$164.84K
Barrett Ronald W
Director
11,750
0.0192%
$164.84K
McNulty Alana B.
Director
6,250
0.0102%
$87.68K
Insider
Date
Role
Action
Shares
Price
Amount
Doyle Janeen Noel
2 Jun 2026
Chief Corp. & Bus. Dev. Ofcr
Sell
4,059
$14.03
$56.94K
Dobek Maria
11 May 2026
Vice President, Accounting
Sell
2,038
$14.17
$28.88K
Dobek Maria
2 Jan 2026
Vice President, Accounting
Sell
1,462
$13.73
$20.07K
McIver Zachariah
2 Jan 2026
Chief Medical Officer
Sell
2,714
$13.73
$37.26K
Winter Charles M.
2 Jan 2026
Chief Technical Officer
Sell
2,401
$13.73
$32.97K
Campbell David Alan
2 Jan 2026
President and CEO
Sell
8,072
$13.73
$110.83K
DiRaimondo Thomas
2 Jan 2026
Chief Scientific Officer
Sell
2,505
$13.73
$34.39K
Meyer Andrew Hollman
2 Jan 2026
Chief Business Officer
Sell
1,879
$13.73
$25.80K
Meyer Andrew Hollman
2 Jan 2025
Chief Business Officer
Sell
200
$57.37
$11.47K
Meyer Andrew Hollman
2 Jan 2025
Chief Business Officer
Sell
1,000
$56.78
$56.78K
Meyer Andrew Hollman
2 Jan 2025
Chief Business Officer
Sell
3,444
$55.76
$192.03K
Meyer Andrew Hollman
2 Jan 2025
Chief Business Officer
Sell
5,768
$54.51
$314.42K
Meyer Andrew Hollman
2 Jan 2025
Chief Business Officer
Sell
2,922
$53.76
$157.08K
Avalon Ventures XI, L.P.
18 Oct 2024
10% owner
Sell indirect
553,219
$44.75
$24.76M
Avalon Ventures XI, L.P.
18 Oct 2024
10% owner
Sell indirect
104,957
$44.75
$4.70M
Avalon Ventures XI, L.P.
18 Oct 2024
10% owner
Sell
541,824
$44.75
$24.25M
Avalon Ventures XI, L.P.
18 Oct 2024
10% owner
Sell indirect
15,788
$51.18
$808.03K
Avalon Ventures XI, L.P.
18 Oct 2024
10% owner
Sell indirect
2,995
$51.18
$153.28K
Avalon Ventures XI, L.P.
18 Oct 2024
10% owner
Sell
15,462
$51.18
$791.35K
Avalon Ventures XI, L.P.
18 Oct 2024
10% owner
Sell indirect
104,892
$50.30
$5.28M
Avalon Ventures XI, L.P.
18 Oct 2024
10% owner
Sell indirect
19,900
$50.30
$1.00M
Avalon Ventures XI, L.P.
18 Oct 2024
10% owner
Sell
102,732
$50.30
$5.17M
Avalon Ventures XI, L.P.
26 Sep 2024
10% owner
Sell indirect
41,661
$47.77
$1.99M
Avalon Ventures XI, L.P.
26 Sep 2024
10% owner
Sell indirect
7,908
$47.77
$377.77K
Avalon Ventures XI, L.P.
26 Sep 2024
10% owner
Sell
40,803
$47.77
$1.95M
Avalon Ventures XI, L.P.
26 Sep 2024
10% owner
Sell indirect
50,539
$46.78
$2.36M
Avalon Ventures XI, L.P.
26 Sep 2024
10% owner
Sell indirect
9,592
$46.78
$448.71K
Avalon Ventures XI, L.P.
26 Sep 2024
10% owner
Sell
49,497
$46.78
$2.32M
Avalon Ventures XI, L.P.
12 Sep 2024
10% owner
Sell indirect
161,356
$47.00
$7.58M
Avalon Ventures XI, L.P.
12 Sep 2024
10% owner
Sell indirect
30,613
$47.00
$1.44M
Avalon Ventures XI, L.P.
12 Sep 2024
10% owner
Sell
158,031
$47.00
$7.43M
Avalon Ventures XI, L.P.
10 Sep 2024
10% owner
Sell indirect
35,047
$46.66
$1.64M
Avalon Ventures XI, L.P.
10 Sep 2024
10% owner
Sell indirect
6,649
$46.66
$310.24K
Avalon Ventures XI, L.P.
10 Sep 2024
10% owner
Sell
34,326
$46.66
$1.60M
Avalon Ventures XI, L.P.
10 Sep 2024
10% owner
Sell indirect
11,557
$46.13
$533.12K
Avalon Ventures XI, L.P.
10 Sep 2024
10% owner
Sell indirect
2,193
$46.13
$101.16K
Avalon Ventures XI, L.P.
10 Sep 2024
10% owner
Sell
11,319
$46.13
$522.15K
Avalon Ventures XI, L.P.
6 Sep 2024
10% owner
Sell indirect
110,644
$42.00
$4.65M
Avalon Ventures XI, L.P.
6 Sep 2024
10% owner
Sell indirect
20,991
$42.00
$881.62K
Avalon Ventures XI, L.P.
6 Sep 2024
10% owner
Sell
108,365
$42.00
$4.55M
Avalon Ventures XI, L.P.
3 Jun 2024
10% owner
Sell indirect
691,525
$54.75
$37.86M
Avalon Ventures XI, L.P.
3 Jun 2024
10% owner
Sell indirect
131,196
$54.75
$7.18M
Avalon Ventures XI, L.P.
3 Jun 2024
10% owner
Sell
677,279
$54.75
$37.08M
Reardon Tighe
3 Jun 2024
Acting Chief Financial Officer
Sell indirect
691,525
$54.75
$37.86M
Reardon Tighe
3 Jun 2024
Acting Chief Financial Officer
Sell indirect
131,196
$54.75
$7.18M
Lichter Jay
3 Jun 2024
Director
Sell indirect
691,525
$54.75
$37.86M
Lichter Jay
3 Jun 2024
Director
Sell indirect
131,196
$54.75
$7.18M
Lichter Jay
3 Jun 2024
Director
Sell indirect
677,279
$54.75
$37.08M
Thompson Peter A.
29 Dec 2021
Director
Sell indirect
3,700
$20.30
$75.11K
Thompson Peter A.
29 Dec 2021
Director
Sell indirect
36,700
$20.30
$745.01K
ORBIMED ADVISORS LLC
29 Dec 2021
Director
Sell indirect
3,700
$20.30
$75.11K
ORBIMED ADVISORS LLC
29 Dec 2021
Director
Sell indirect
36,700
$20.30
$745.01K
Thompson Peter A.
21 Dec 2021
Director
Sell indirect
11,100
$19.00
$210.90K
Thompson Peter A.
21 Dec 2021
Director
Sell indirect
108,300
$19.00
$2.06M
ORBIMED ADVISORS LLC
21 Dec 2021
Director
Sell indirect
11,100
$19.00
$210.90K
ORBIMED ADVISORS LLC
21 Dec 2021
Director
Sell indirect
108,300
$19.00
$2.06M
ORBIMED ADVISORS LLC
16 Dec 2021
Director
Sell indirect
36,500
$19.07
$696.06K
ORBIMED ADVISORS LLC
16 Dec 2021
Director
Sell indirect
356,800
$19.07
$6.80M
Thompson Peter A.
16 Dec 2021
Director
Sell indirect
36,500
$19.07
$696.06K
Thompson Peter A.
16 Dec 2021
Director
Sell indirect
356,800
$19.07
$6.80M

What was left out

Form 4 filings counted 136
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 22
Sales on a Rule 10b5-1 plan 12
Sales straight out of an exercise 31
Sales at will 60
Transactions with no price 0
Shares from compensation/vesting 36,004,274
Sales filed before the plan box existed 12
History held since 14 Jun 2021